FDA Investigator Joseph Brady
Joseph Brady has conducted inspections on 23 sites in 1 countries as of 12 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
12 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Joseph Brady:
Alan D Centi,
Alexandra B Pitkin,
Alfred Puglia,
Anthony A Charity,
Audrey Thereset Uy,
Brian D Young,
Brian Ravitch,
Brian S Keefer,
Cara M Minelli,
Cathleen A Carr Sharpe,
Crayton Lee,
Crystal A Harlan,
Daniel W Johnson,
Darrin E Davis,
Dauksism,
David A Schwartz,
David G Whitman,
Deborah G Haney Cozzone,
Deborah H Cozzone,
Debra J Bennett,
Debra J Fracassa,
Denise H Howell,
Donyel M Jones,
Edwin L Hobbs,
Elizabeth M Dahl,
Fe Q Reyes,
Gayle S Lawson,
Gerald W Kopp,
Gordon Chu,
Hai T Truong,
Henry E Carrillo,
James P Mcevoy,
James P Stallings,
Jeannie Pradyanata,
Jeannie R Mayberry,
Jeen S Min,
Jeff M Uriarte,
Jessica M Monteiro,
Jinnie Kokiatkulkij,
Joey V Quitania,
Joseph C Francisco,
Joseph S Fanelli,
Joseph T Dougherty,
Judith A Paterson,
Judy C Nepsa,
Julianne C Mccullough,
Kevin T Gerrity,
Kim G Campbell,
Kimberly M Lichter,
Kristina J Donohue,
Kyle D Covill,
Lilly O Barton,
Linda M Hoover,
Linda M Ross,
Linda Thai,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Magdi Ali,
Mark Gray,
Martha Sullivan Myrick,
Matthew R Noonan,
Maureen A Wentzel,
Melissa M Dauksis,
Meredith L Sheridan,
Michael A Taylor,
Michele M Falchek,
Natalie J Ayoub,
Nikisha M Bolden,
Othello G Capangpangan,
Raffi B Papazian,
Raymond L Cheung,
Richard E Jewell,
Ronald T Colucci,
Saied A Asbagh,
Sara Jdent Acosta,
Sarah A Hassas,
Sarah K Graham,
Sarah K Lemin,
Sean P Desbrow,
Seng Ching Hwang,
Sonya L Karsik, RAC,
Sparky L Bartee,
Stephanie Mangigian, MS/OSH, RN,
Tammy Vasquez Hancock,
Thao T Kwan,
Thomas E Friel,
Todd J Maushart,
Tonya O Corbin,
Vlada Matusovsky,
Whitney S Reynolds,
Xinyi Hui,
Yessika Mashinski,
Yvette Mlacour Davis
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more